Literature DB >> 8955522

Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders.

D A Loeffler1, P A LeWitt, P L Juneau, A A Sima, H U Nguyen, A J DeMaggio, C M Brickman, G J Brewer, R D Dick, M D Troyer, L Kanaley.   

Abstract

Ceruloplasmin (CP), the major plasma anti-oxidant and copper transport protein, is synthesized in several tissues, including the brain. We compared regional brain concentrations of CP and copper between subjects with Alzheimer's disease (AD, n = 12), Parkinson's disease (PD, n = 14), Huntington's disease (HD, n = 11), progressive supranuclear palsy (PSP, n = 11), young adult normal controls (YC, n = 6) and elderly normal controls (EC, n = 7). Mean CP concentrations were significantly increased vs. EC (P < 0.05) in AD hippocampus, entorhinal cortex, frontal cortex, and putamen. PD hippocampus, frontal, temporal, and parietal cortices, and HD hippocampus, parietal cortex, and substantia nigra. Immunocytochemical staining for CP in AD hippocampus revealed marked staining within neurons, astrocytes, and neuritic plaques. Increased CP concentrations in brain in these disorders may indicate a localized acute phase-type response and/or a compensatory increase to oxidative stress.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8955522     DOI: 10.1016/s0006-8993(96)00782-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  49 in total

1.  The effect of formalin fixation on the levels of brain transition metals in archived samples.

Authors:  Matthew Schrag; April Dickson; Arshad Jiffry; David Kirsch; Harry V Vinters; Wolff Kirsch
Journal:  Biometals       Date:  2010-06-26       Impact factor: 2.949

2.  Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction.

Authors:  Latha Devi; Badanavalu M Prabhu; Domenico F Galati; Narayan G Avadhani; Hindupur K Anandatheerthavarada
Journal:  J Neurosci       Date:  2006-08-30       Impact factor: 6.167

3.  Membrane-mediated amyloidogenesis and the promotion of oxidative lipid damage by amyloid beta proteins.

Authors:  Ian V J Murray; Liu Liu; Hiroaki Komatsu; Kunihiro Uryu; Gang Xiao; John A Lawson; Paul H Axelsen
Journal:  J Biol Chem       Date:  2007-01-24       Impact factor: 5.157

Review 4.  Mitochondrial metals as a potential therapeutic target in neurodegeneration.

Authors:  A Grubman; A R White; J R Liddell
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

5.  Plasma proteomic analysis of simian immunodeficiency virus infection of rhesus macaques.

Authors:  Jayme L Wiederin; Robert M Donahoe; James R Anderson; Fang Yu; Howard S Fox; Howard E Gendelman; Pawel S Ciborowski
Journal:  J Proteome Res       Date:  2010-09-03       Impact factor: 4.466

6.  Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer's disease.

Authors:  H Kessler; F-G Pajonk; P Meisser; T Schneider-Axmann; K-H Hoffmann; T Supprian; W Herrmann; R Obeid; G Multhaup; P Falkai; T A Bayer
Journal:  J Neural Transm (Vienna)       Date:  2006-06-01       Impact factor: 3.575

7.  Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides.

Authors:  Xudong Huang; Craig S Atwood; Robert D Moir; Mariana A Hartshorn; Rudolph E Tanzi; Ashley I Bush
Journal:  J Biol Inorg Chem       Date:  2004-11-03       Impact factor: 3.358

Review 8.  Oxidative stress signaling in Alzheimer's disease.

Authors:  B Su; X Wang; A Nunomura; P I Moreira; H-gon Lee; G Perry; M A Smith; X Zhu
Journal:  Curr Alzheimer Res       Date:  2008-12       Impact factor: 3.498

Review 9.  Metal ion physiopathology in neurodegenerative disorders.

Authors:  Silvia Bolognin; Luigi Messori; Paolo Zatta
Journal:  Neuromolecular Med       Date:  2009-11-28       Impact factor: 3.843

10.  Ceruloplasmin (2-D PAGE) Pattern and Copper Content in Serum and Brain of Alzheimer Disease Patients.

Authors:  Rosanna Squitti; Carlo C Quattrocchi; Gloria Dal Forno; Piero Antuono; David R Wekstein; Concetta R Capo; Carlo Salustri; Paolo M Rossini
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.